Knight Therapeutics Inc. (KHTRF)
OTCMKTS · Delayed Price · Currency is USD
4.330
+0.085 (2.00%)
Feb 11, 2026, 9:30 AM EST
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
$398,810
Profits / Employee
-$3,366
Market Cap
430.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 745 | 20 | 2.76% | 745 | 0 |
| Dec 31, 2023 | 725 | 27 | 3.87% | 725 | 0 |
| Dec 31, 2022 | 698 | 38 | 5.76% | 698 | 0 |
| Dec 31, 2021 | 660 | -19 | -2.80% | 660 | 0 |
| Dec 31, 2020 | 679 | - | - | 679 | 0 |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jushi Holdings | 1,234 |
| MariMed | 832 |
| Glass House Brands | 374 |
| Earth Science Tech | 76 |
| Elite Pharmaceuticals | 68 |
| Radnostix | 42 |
| Healthy Extracts | 2 |
Knight Therapeutics News
- 2 months ago - Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris - GlobeNewsWire
- 3 months ago - Knight Therapeutics Inc. (GUD:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Knight Therapeutics Reports Third Quarter 2025 Results - GlobeNewsWire
- 3 months ago - Knight Announces Closing of US$100 Million Revolving Credit Facility - GlobeNewsWire
- 3 months ago - Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call - GlobeNewsWire
- 4 months ago - Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada - GlobeNewsWire
- 4 months ago - Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada - GlobeNewsWire
- 4 months ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail’s seventh annual ranking of Canada’s Top Growing Companies - Financial Post